08/22/2024 6:23 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2024 6:23 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 7:11 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 7:13 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 7:00 PM | Lian Brian (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024 6:47 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024 7:03 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
08/14/2024 3:38 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024 3:05 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2024 3:05 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2024 3:05 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/30/2024 4:55 PM | Lian Brian (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024 4:56 PM | Mancini Marianna (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024 4:58 PM | Viking Therapeutics (Subject) ZANTE GREG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024 4:00 PM | Viking Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024 3:10 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/04/2024 6:10 AM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/22/2024 6:46 PM | Viking Therapeutics (Filer)
| Form S-8 POS | |
05/22/2024 6:54 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/22/2024 3:33 PM | Viking Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/03/2024 7:51 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2024 3:04 PM | Viking Therapeutics (Subject) ZANTE GREG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024 8:27 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2024 3:02 PM | Mancini Marianna (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/24/2024 7:42 PM | Viking Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024 3:05 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/05/2024 3:15 PM | Viking Therapeutics (Filer)
| Form ARS | |
03/27/2024 7:50 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 7:51 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 7:52 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2024 6:08 AM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/04/2024 6:50 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:52 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:54 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 3:52 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/01/2024 3:05 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 4:21 PM | Viking Therapeutics (Filer)
| Form 424B5 | |
02/27/2024 6:04 AM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/09/2024 7:59 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:38 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:40 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8933&Placement=NativeDisplay&Source=NativeDisplay) Register For The Webinar To Discover |
02/07/2024 4:24 PM | Viking Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/07/2024 4:33 PM | Viking Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/31/2024 7:39 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:32 PM | Lian Brian (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024 8:05 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 3:23 PM | Lian Brian (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024 12:24 PM | STATE STREET CORP (Filed by) Viking Therapeutics (Subject)
| Form SC 13G/A | |
01/19/2024 7:35 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:36 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 3:26 PM | MILLENNIUM MANAGEMENT LLC (Filed by) Viking Therapeutics (Subject)
| Form SC 13G/A | |
01/04/2024 8:35 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:36 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:37 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:22 PM | FOEHR MATTHEW W (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:24 PM | MACARTNEY LAWSON (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:25 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:27 PM | Rowland Charles A Jr (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:28 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 7:12 PM | Viking Therapeutics (Subject) ZANTE GREG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023 3:30 PM | VIKING GLOBAL INVESTORS LP (Filed by) Viking Therapeutics (Subject)
| Form SC 13G | |
10/25/2023 4:05 PM | Viking Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/25/2023 3:24 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |